Abstract
Central serous chorioretinopathy (CSC) was originally described by Albrecht von Graefe in 1866 as “central recurrent retinitis” (Von Graefe 1866). Since then our understanding of CSC has progressed considerably. Gass in 1967 named the disease as central serous chorioretinopathy and proposed choriocapillaris hyperpermeability as the cause of CSC (Gass 1967). This hypothesis was later supported by studies using indocyanine green angiography (ICGA) which showed multifocal areas of choroidal vascular hyperpermeability in eyes with CSC.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahn SE, Oh J, Oh JH et al (2013) Three-dimensional configuration of subretinal fluid in central serous chorioretinopathy. Invest Ophthalmol Vis Sci 54:5944–5952
Bajarborua D (2001) Long-term follow-up of idiopathic central serous chorioretinopathy without laser. Acta Ophthalmol Scand 79:417–421
Castro-Correia J, Coutinho MF, Rosas V et al (1992) Long term follow up of central serous retinopathy in 150 patients. Doc Ophthalmol 81:379–386
Chan WM, Lam DS, Lai TY et al (2003) Treatment of choroidal neovascularization in central serous chorioretinopathy by photodynamic therapy with verteporfin. Am J Ophthalmol 136:836–845
Chan WM, Lai TY, Lai RY et al (2008) Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial. Ophthalmology 115:1756–1765
Cho M, Athanikar A, Paccione J et al (2010) Optical coherence tomography features of acute central serous chorioretinopathy versus neovascular age-related macular degeneration. Br J Ophthalmol 94:597–599
Ciardella AP, Donsoff IM, Huang SJ et al (2004) Polypoidal choroidal vasculopathy. Surv Ophthalmol 49:25–37
Cooper BA, Thomas MA (2000) Submacular surgery to remove choroidal neovascularization associated with central serous chorioretinopathy. Am J Ophthalmol 130:187–191
Ellabban AA, Tsujikawa A, Ooto S et al (2013) Focal choroidal excavation in eyes with central serous chorioretinopathy. Am J Ophthalmol 56:673–683
Fawzi AA, Holland GN, Kreiger AE et al (2006) Central serous chorioretinopathy after solid organ transplantation. Ophthalmology 113:805–813
Ferrara D, Mohler KJ, Waheed N et al (2014) En-face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy. Ophthalmology 121:719–726
Fong AH, Li KK, Wong D (2011) Choroidal evaluation using enhanced depth imaging spectral-domain optical coherence tomography in Vogt-Koyanagi-Harada disease. Retina 31:502–509
Fujimoto H, Gomi F, Wakabayashi T et al (2008) Morphologic changes in acute central serous chorioretinopathy evaluated by Fourier-domain optical coherence tomography. Ophthalmology 115:1494–1500
Fung AT, Yannuzzi LA, Freund KB (2012) Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration. Retina 32:1829–1837
Gäckle HC, Lang GE, Freissler KA et al (1998a) Central serous chorioretinopathy. Clinical, fluorescein angiography and demographic aspects. Ophthalmologe 95:529–533
Gäckle HC, Lang GE, Freidler KA et al (1998b) Clinical fluorescein angiographic and demographic aspects in central serous chorioretinopathy. Ophthalmologe 95:529–533
Gass JDM (1967) Pathogenesis of disciform detachment of the neuroepithelium: II. Idiopathic central serous choroidopathy. Am J Ophthalmol 63:587–615
Gass JDM (1973) Bullous retinal detachment. An unusual manifestation of idiopathic central serous choroidopathy. Am J Ophthalmol 75:810–882
Gass JDM (1991) Central serous chorioretinopathy and white subretinal exudation during pregnancy. Arch Ophthalmol 109:677–681
Gass JDM (1992) Bullous retinal detachment and multiple retinal pigment epithelium detachments in patients receiving haemodialysis. Graefes Arch ClinExpOphthalmol 230:454–458
Gass JDM, Little H (1995) Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid therapy. Ophthalmology 102:737–747
Gupta V, Gupta A, Gupta P et al (2009) Spectral-domain cirrus optical coherence tomography of choroidal striations seen in the acute stage of Vogt-Koyanagi-Harada disease. Am J Ophthalmol 147:148–153
Gupta V, Gupta P, Dogra MR et al (2010a) Spontaneous closure of retinal pigment epithelium microrip in the natural course of central serous chorioretinopathy. Eye (Lond) 24:595–599
Gupta P, Gupta V, Dogra MR et al (2010b) Morphological changes in the retinal pigment epithelium on spectral-domain OCT in the unaffected eyes with idiopathic central serous chorioretinopathy. Int Ophthalmol 30:175–181
Hooymans JM (1998) Fibrotic scar formation in central serous chorioretinopathy developed during systemic treatment with corticosteroids. Graefes Arch Clin Exp Ophthalmol 236:876–879
Iida T, Spaide RF, Haas A et al (2002) Leopard-spot pattern of yellowish subretinal deposits in central serous chorioretinopathy. Arch Ophthalmol 120:37–42
Imamura Y, Fujiwara T, Margolis R et al (2009) Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina 29:1469–1473
Imamura Y, Fujiwara T, Spaide RF (2011) Fundus autofluorescence and visual acuity in central serous chorioretinopathy. Ophthalmology 118:700–705
Ishihara K, Hangai M, Kita M et al (2009) Acute Vogt-Koyanagi-Harada disease in enhanced spectral-domain optical coherence tomography. Ophthalmology 116:1799–1807
Kim HC, Cho WB, Chung H (2012) Morphologic changes in acute central serous chorioretinopathy using spectral domain optical coherence tomography. Korean J Ophthalmol 26:347–354
Kim SK, Kim SW, Oh J et al (2013) Near-infrared and short-wavelength autofluorescence in resolved central serous chorioretinopathy: association with outer retinal layer abnormalities. Am J Ophthalmol 156:157–164
Kitaya N, Nagaoka T, Hikichi T et al (2003) Features of abnormal choroidal circulation in central serous chorioretinopathy. Br J Ophthalmol 87:709–712
Koizumi H, Yamagishi T, Yamazaki T et al (2013) Relationship between clinical characteristics of polypoidal choroidal vasculopathy and choroidal vascular hyperpermeability. Am J Ophthalmol 155:305–313
Konstantinidis L, Mantel I, Zografos L et al (2010) Intravitreal ranibizumab in the treatment of choroidal neovascularization associated with idiopathic central serous chorioretinopathy. Eur J Ophthalmol 20:955–958
Lanzetta P, Furlan F, Morgante L et al (2008) Nonvisible subthreshold micropulse diode laser (810 nm) treatment of central serous chorioretinopathy. A pilot study. Eur J Ophthalmol 18:934–940
Lee JH, Lee WK (2014) Choroidal neovascularization associated with focal choroidal excavation. Am J Ophthalmol 157:710–718
Lee SB, Kim JY, Kim WJ et al (2013) Bilateral central serous chorioretinopathy with retinal pigment epithelium tears following epidural steroid injection. In J Ophthalmol 61:514–515
Lee CS, Woo SJ, Kim YK et al (2014) Clinical and spectral-domain optical coherence tomography findings in patients with focal choroidal excavation. Ophthalmology 121:1029–1035
Lehmann M, Wolff B, Vasseur V et al (2013) Retinal and choroidal changes observed with ‘En-face’ enhanced-depth imaging OCT in central serous chorioretinopathy. Br J Ophthalmol 97:1181–1186
Levine R, Brucker AJ, Robinson F (1989) Long-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography. Ophthalmology 96:854–859
Liegl R, Ulbig MW (2014) Central serous chorioretinopathy. Ophthalmologica 232:65–76, Epub ahead of print
Lumbroso B, Savastano MC, Rispoli M et al (2011) Morphologic differences, according to etiology, in pigment epithelial detachments by means of en-face optical coherence tomography. Retina 31:553–558
Luk FO, Fok AC, Lee A et al (2015) Focal choroidal excavation in patients with central serous chorioretinopathy. Eye (Lond) 29:453–459
Maruko I, Iida T, Sugano Y et al (2010) Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology 117:1792–1799
Maruko I, Iida T, Ojima A et al (2011a) Subretinal dot-like precipitates and yellow material in central serous chorioretinopathy. Retina 31:759–765
Maruko I, Tomohiro I, Sugano Y et al (2011b) Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease. Retina 31:510–517
Matsumoto H, Sato T, Kishi S (2009) Outer nuclear layer thickness at the fovea determines visual outcomes in resolved central serous chorioretinopathy. Am J Ophthalmol 148:105–110
Matsunaga H, Nangoh K, Uyama M et al (1995) Occurrence of choroidal neovascularization following photocoagulation treatment for central serous retinopathy. Nippon GankaGakkaiZasshi 99:460–468
Miki A, Kondo N, Yanagisawa S et al (2014) Common variants in the complement factor h gene confer genetic susceptibility to central serous chorioretinopathy. Ophthalmology 121:1067–1072
Montero JA, Ruiz-Moreno JM, Fernandez-Muñoz M (2011) Intravitreal bevacizumab to treat choroidal neovascularization following photodynamic therapy in central serous choroidopathy. Eur J Ophthalmol 21:503–505
Mrejen S, Spaide RF (2013) Optical coherence tomography: imaging of the choroid and beyond. Surv Ophthalmol 58:387–429
Nair U, Ganekal S, Soman M et al (2012) Correlation of spectral domain optical coherence tomography findings in acute central serous chorioretinopathy with visual acuity. Clin Ophthalmol 6:1949–1954
Nazari H, Hariri A, Hu Z et al (2014) Choroidal atrophy and loss of choriocapillaris in convalescent stage of Vogt-Koyanagi-Harada disease: in vivo documentation. J Ophthalmic Inflamm Infect 4:9
Nicholson B, Noble J, Forooghian F et al (2013) Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol 58:103–126
Nomura Y, Obata R, Yanagi Y (2012) Intravitreal bevacizumab for iatrogenic choroidal neovascularization due to laser photocoagulation in central serous chorioretinopathy. Jpn J Ophthalmol 56:245–249
Odrobina D, Laudańska-Olszewska I, Gozdek P et al (2013) Morphologic changes in the foveal photoreceptor layer before and after laser treatment in acute and chronic central serous chorioretinopathy documented in spectral-domain optical coherence tomography. J Ophthalmol 2013:361513
Ojima Y, Hangai M, Sasahara M et al (2007) Three-dimensional imaging of the foveal photoreceptor layer in central serous chorioretinopathy using high-speed optical coherence tomography. Ophthalmology 114:2197–2207
Ooto S, Tsujikawa A, Mori S et al (2010) Thickness of photoreceptor layers in polypoidal choroidal vasculopathy and central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 248:1077–1086
Ooto S, Tsujikawa A, Mori S et al (2011) Retinal microstructural abnormalities in central serous chorioretinopathy and polypoidal choroidal vasculopathy. Retina 31:527–534
Otsuka S, Ohnba N, Nakao K (2002) A long-term follow-up study of severe variant of central serous chorioretinopathy. Retina 22:25–32
Ozdemir O, Erol MK (2014) Morphologic changes and visual outcomes in resolved central serous chorioretinopathy treated with ranibizumab. Cutan Ocul Toxicol 33(2):122–126, Epub ahead of print
Polak BCP, Baarsma GS, Snyers B (1995) Diffuse retinal pigment epitheliopathy complicating systemic corticosteroid treatment. Br J Ophthalmol 79:922–925
Pryds A, Larsen M (2013) Foveal function and thickness after verteporfin photodynamic therapy in central serous chorioretinopathy with hyperautofluorescent subretinal deposits. Retina 33:128–135
Quin G, Liew G, Ho IV et al (2013) Diagnosis and interventions for central serous chorioretinopathy: review and update. Clin Exp Ophthalmol 41:187–200
Reibaldi M, Cardascia N, Longo A et al (2010) Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial. Am J Ophthalmol 149:307–315
Rogers AH, Martidis A, Greenberg PB et al (2002) Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization. Am J Ophthalmol 134:566–576
Roisman L, Magalhães FP, Lavinsky D et al (2013) Micropulse diode laser treatment for chronic central serous chorioretinopathy: a randomized pilot trial. Ophthalmic Surg Lasers Imaging Retina 44:465–470
Ross A, Ross AH, Mohamed Q (2011) Review and update of central serous chorioretinopathy. Curr Opin Ophthalmol 22:166–173
Sahu DK, Namperumalsamy P, Hilton GF et al (2000) Bullous variant of idiopathic central serous chorioretinopathy. Br J Ophthalmol 84:485–492
Sakata VM, da Silva FT, Hirata CE et al (2014) Choroidal bulging in patients with Vogt-Koyanagi-Harada disease in the non-acute uveitic stage. J Ophthalmic Inflamm Infect 4:6
Sasahara M, Tsujikawa A, Musashi K et al (2006) Polypoidal choroidal vasculopathy with choroidal vascular hyperpermeability. Am J Ophthalmol 142:601–607
Sato T, Kishi S, Watanabe G, Matsumoto H, Mukai R (2007) Tomographic features of branching vascular networks in polypoidal choroidal vasculopathy. Retina 27:589–594
Schatz H, McDonald HR, Johnson RN et al (1995) Subretinal fibrosis in central serous chorioretinopathy. Ophthalmology 102:1077–1088
Sekiryu T, Iida T, Maruko I et al (2010) Infrared fundus autofluorescence and central serous chorioretinopathy. Invest Ophthalmol Vis Sci 51:4956–4962
Shinojima A, Hirose T, Mori R et al (2010) Morphologic findings in acute central serous chorioretinopathy using spectral domain-optical coherence tomography with simultaneous angiography. Retina 30:193–202
Song IS, Shin YU, Lee BR (2012) Time-periodic characteristics in the morphology of idiopathic central serous chorioretinopathy evaluated by volume scan using spectral-domain optical coherence tomography. Am J Ophthalmol 154:366–375
Spaide RF, Koizumi H, Pozzoni MC (2008) Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol 146:496–500
Suzuki M, Gomi F, Hara C et al (2014) Characteristics of central serous chorioretinopathy complicated by focal choroidal excavation. Retina 4(6):1216–1222 [Epub ahead of print]
Vasconcelos-Santos DV, Sohn EH, Sadda S et al (2010) Retinal pigment epithelial changes in chronic Vogt-Koyanagi-Harada disease: fundus autofluorescence and spectral domain-optical coherence tomography findings. Retina 30:33–41
Von Graefe A (1866) Ueber central recidivierende retinitis. Graefes Arch Clin Exp Ophthalmol 12:211–215
Wang M, Sander B, la Cour M et al (2005) Clinical characteristics of subretinal deposits in central serous chorioretinopathy. Acta Ophthalmol Scand 83:691–696
Wojtkowski M, Srinivasan V, Fujimoto JG et al (2005) Three-dimensional retinal imaging with high speed ultrahigh resolution optical coherence tomography. Ophthalmology 112:1734–1746
Yalcinbayir O, Gelisken O, Akova-Budak B et al (2014) Correlation of spectral domain optical coherence tomography findings and visual acuity in central serous chorioretinopathy. Retina 34:705–712
Yang L, Jonas JB, Wei W et al (2013) Optical coherence tomography assisted enhanced depth imaging of central serous chorioretinopathy. Invest Ophthalmol Vis Sci 54:4659–4665
Yannuzzi LA, Shakin JL, Fisher YL et al (1984) Peripheral retinal detachments and retinal pigment epithelial atrophic tracts secondary to central serous pigment epitheliopathy. Ophthalmology 91:1554–1572
Yannuzzi LA, Slakter JS, Gross NE et al (2012) Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina 32(Suppl 1):288–298
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer India
About this chapter
Cite this chapter
Fong, A.H.C., Lai, T.Y.Y. (2017). Central Serous Chorioretinopathy. In: Meyer, C., Saxena, S., Sadda, S. (eds) Spectral Domain Optical Coherence Tomography in Macular Diseases. Springer, New Delhi. https://doi.org/10.1007/978-81-322-3610-8_18
Download citation
DOI: https://doi.org/10.1007/978-81-322-3610-8_18
Published:
Publisher Name: Springer, New Delhi
Print ISBN: 978-81-322-3608-5
Online ISBN: 978-81-322-3610-8
eBook Packages: MedicineMedicine (R0)